January 31, 2008 — Cannabis withdrawal is clinically important and warrants inclusion in the Diagnostic and Statistical Manual ( DSM), researchers argue in an article in the January 1 issue of Drug ...

PHOENIXVILLE, Pa., June 15, 2026 /PRNewswire/ -- PleoPharma, a clinical-stage clinical development company focused on cannabis-related health issues, announced today that it will present two posters ...

Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. Pharmaceutical development company PleoPharma has received a ...

PleoPharma, Inc., a clinical-stage development company focused on cannabis-related health issues, today announced that the first patient has been dosed in CAN-004, a Phase 3 clinical trial evaluating ...

(The Conversation) – In stark contrast to the overblown fears portrayed during decades past, these days, most people think cannabis is relatively harmless. While weed is indeed less dangerous than ...

A reader of this blog recently asked me for help abstaining from his frequent cannabis use. I responded with advice later summarized in my post "Practical Advice on How To Quit Cannabis." In exchange, ...

Better clinical screening and updated provider training foster open communication to identify cannabis-related health risks ...

Presentations will highlight the patient experience of cannabis withdrawal/cannabis use disorder and Phase 2 CAN-002 data for investigational PP-01 in adults with cannabis use disorder PHOENIXVILLE, ...